The TROP2 paradox: enhancing precision in immunotherapy for advanced non-small cell lung cancer patients-a commentary

被引：0
|
作者：
Khan, Saqib Raza [1 ,2 ]
Verma, Saurav [1 ,2 ]
Breadner, Daniel [1 ,2 ]
Raphael, Jacques [1 ,2 ,3 ]
机构：
[1] Western Univ, Schulich Sch Med & Dent, Dept Oncol, Div Med Oncol, London, ON, Canada
[2] London Hlth Sci Ctr, Verspeeten Family Canc Ctr, London, ON, Canada
[3] Lawson Hlth Res Inst, London, ON, Canada
来源：
TRANSLATIONAL CANCER RESEARCH | 2025年 / 14卷 / 02期
关键词：
Lung cancer; immunotherapy; biomarker; resistance; TROP2; PLUS PEMBROLIZUMAB PEMBRO; DATOPOTAMAB DERUXTECAN; SACITUZUMAB GOVITECAN; OPEN-LABEL; ATEZOLIZUMAB; CHEMOTHERAPY; MULTICENTER; DOCETAXEL; COHORT; NSCLC;
D O I：
10.21037/tcr-24-1633
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：660 / 666
页数：7
相关论文
共 50 条
  • [41] Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
    Yimin Wang
    Chuling Li
    Zimu Wang
    Zhaofeng Wang
    Ranpu Wu
    Ying Wu
    Yong Song
    Hongbing Liu
    BMC Medicine, 20
  • [42] Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
    Wang, Yimin
    Li, Chuling
    Wang, Zimu
    Wang, Zhaofeng
    Wu, Ranpu
    Wu, Ying
    Song, Yong
    Liu, Hongbing
    BMC MEDICINE, 2022, 20 (01)
  • [43] Clinical value of serum trophoblast cell surface protein 2 (TROP2) antibody in non-small-cell lung cancer patients
    Zheng, Zhuan
    Dong, Xue-Jun
    BIOMARKERS, 2016, 21 (08) : 739 - 742
  • [44] Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer
    Tsukita, Yoko
    Tozuka, Takehiro
    Kushiro, Kohei
    Hosokawa, Shinobu
    Sumi, Toshiyuki
    Uematsu, Mao
    Honjo, Osamu
    Yamaguchi, Ou
    Asao, Tetsuhiko
    Sugisaka, Jun
    Saito, Go
    Shiihara, Jun
    Morita, Ryo
    Katakura, Seigo
    Yasuda, Takehiro
    Hisakane, Kakeru
    Miyauchi, Eisaku
    Morita, Satoshi
    Kobayashi, Kunihiko
    Asahina, Hajime
    JAMA ONCOLOGY, 2024, 10 (04) : 439 - 447
  • [45] Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Tsiara, Anna
    Liontos, Michalis
    Kaparelou, Maria
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [46] Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
    Chaunzwa, Tafadzwa L.
    Qian, Jack M.
    Li, Qin
    Ricciuti, Biagio
    Nuernberg, Leonard
    Johnson, Justin W.
    Weiss, Jakob
    Zhang, Zhongyi
    MacKay, Jamie
    Kagiampakis, Ioannis
    Bikiel, Damian
    Di Federico, Alessandro
    Alessi, Joao V.
    Mak, Raymond H.
    Jacob, Etai
    Awad, Mark M.
    Aerts, Hugo J. W. L.
    JAMA ONCOLOGY, 2024, 10 (06) : 773 - 783
  • [47] Emerging Role of Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Mulherkar, Ria
    Grewal, Amardeep S.
    Berman, Abigail T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (04) : 212 - 217
  • [48] Chemotherapy in patients with advanced non-small cell lung cancer
    Price, A
    CLINICAL ONCOLOGY, 2001, 13 (06) : 480 - 482
  • [49] Advanced non-small cell lung cancer in elderly patients
    Quoix, Elisabeth
    BREATHE, 2012, 9 (01) : 27 - 34
  • [50] Stratification in advanced non-small cell lung cancer: precision medicine in practice
    Brustugun, Odd Terje
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2016, 1 (03): : 279 - 287
12345